Epigenetic alteration and microRNA dysregulation in cancer

Hiromu Suzuki1, Reo Maruyama1, Eiichiro Yamamoto1

  • 1Department of Molecular Biology, Sapporo Medical University Sapporo, Japan.

Frontiers in Genetics
|December 19, 2013
PubMed

Insights

Epigenetic changes like DNA methylation and histone modifications disrupt microRNAs (miRNAs) in cancer. Understanding these epigenetic alterations in miRNA genes offers potential cancer biomarkers and therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • MicroRNAs (miRNAs) are crucial regulators of biological processes.
  • Dysregulation of miRNAs is a hallmark of human cancers.
  • Epigenetic alterations are increasingly recognized as key drivers of miRNA dysregulation in cancer.

Purpose of the Study:

  • To explore the intricate relationship between epigenetic modifications and miRNA dysregulation in cancer.
  • To highlight the potential of epigenetic alterations in miRNA genes as cancer biomarkers.
  • To investigate miRNA re-expression as a therapeutic strategy for cancer.

Main Methods:

  • Analysis of the cancer epigenome.
  • Investigation of DNA methylation patterns (hypermethylation and hypomethylation) affecting miRNA genes.
  • Examination of histone modifications (e.g., deacetylation, repressive marks) associated with miRNA gene silencing.

Main Results:

  • Aberrant DNA methylation (CpG island hypermethylation and DNA hypomethylation) significantly impacts miRNA expression in cancer.
  • Histone modifications, including deacetylation and repressive marks, are linked to miRNA gene silencing.
  • Evidence suggests a causal relationship where miRNA dysregulation is linked to epigenetic alterations in cancer.

Conclusions:

  • Epigenetic alterations in miRNA genes are major contributors to cancer development and progression.
  • Aberrant miRNA methylation serves as a potential biomarker for cancer detection and outcome prediction.
  • Targeting epigenetic modifications to restore miRNA function presents a promising avenue for novel cancer therapies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

9.8K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.5K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K